Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Signal Group is a medical technology company specializing in advanced electroencephalogram (EEG) solutions. The company's flagship product, microEEG, is a miniature, wireless, and portable EEG device designed for rapid deployment in emergency rooms, intensive care units, and remote settings. By simplifying the process of capturing brain activity, Bio-Signal Group enables clinicians to quickly diagnose and monitor neurological conditions such as seizures and status epilepticus. Their technology focuses on high-quality signal acquisition in a compact form factor to improve patient outcomes in critical care environments. The microEEG system is FDA-cleared and designed to integrate with standard hospital networks for remote review by neurologists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Signal Technologies.